
Quorum: Glycopeptide Discovery Via Mass Spectrometry and Spectral NetworkingAward last edited on: 1/7/2022
Sponsored Program
SBIRAwarding Agency
NIH : NIGMSTotal Award Amount
$2,116,994Award Phase
2Solicitation Topic Code
-----Principal Investigator
Anand PatelCompany Information
Abterra Biosciences Inc (AKA: Digital Proteomics LLC~Abterra Biosciences Inc)
3030 Bunker Hill Street Suite 218
San Diego, CA 92109
San Diego, CA 92109
(888) 416-9305 |
info@abterrabio.com |
www.abterrabio.com |
Location: Single
Congr. District: 50
County: San Diego
Congr. District: 50
County: San Diego
Phase I
Contract Number: 1R43GM125485-01A1Start Date: 2/1/2018 Completed: 7/31/2018
Phase I year
2018Phase I Amount
$193,466Public Health Relevance Statement:
While natural products and their derivatives comprise 45% of FDA recently approved drugs, new discoveries by pharmaceutical companies has waned due to the difficulty in isolating novel compounds and lack of high-throughput methods for characterization. Quorum is a software tool that analyzes mass spectrometry data to characterize compounds from microbe rich extracts, as well as track compound behavior across samples or conditions. The innovative molecular networking approach employed by Quorum will dramatically increase the rate for identifying compounds and accelerate discovery of new therapeutics.
Project Terms:
adduct; Anti Inflammatory Analgesics; Anti-Bacterial Agents; Antibiotic Resistance; bacterial resistance; Behavior; Biochemical; Biological; carbapenem resistance; Catalogs; Chemical Structure; Clostridium difficile; combat; Communicable Diseases; Complex; Data; Data Analyses; database structure; Databases; design; Development; digital; Dolastatin Compound; drug discovery; drug resistant bacteria; Environment; environmental stressor; experimental study; Family; follow-up; Genome; Growth; high throughput technology; Imagery; improved; innovation; interest; Investigation; Investments; Lead; Libraries; Lipids; Malignant Neoplasms; Manuals; Mass Spectrum Analysis; member; Methods; Microbe; microbial; Mining; Modification; Molecular; Molecular Biology; Multivariate Analysis; Mutation; Natural Increases; Natural Product Drug; Natural Products; NMR Spectroscopy; novel; novel therapeutics; oncology; Pattern; Peptides; Pharmaceutical Preparations; Pharmacologic Substance; programs; Proteomics; Protocols documentation; Recording of previous events; Research; Research Personnel; Resources; Sampling; Series; social; Software Tools; Source; Statistical Data Interpretation; Structure; success; tandem mass spectrometry; Techniques; Technology; Therapeutic; therapeutic candidate; Time; tool; Visual; web app
Phase II
Contract Number: 2R44GM125485-02A1Start Date: 00/00/00 Completed: 00/00/00
Phase II year
2020(last award dollars: 2021)
Phase II Amount
$1,923,528Public Health Relevance Statement:
Glycans are key modulators of protein stability and function, and play critical roles in host-pathogen interactions, cancer metastasis, and immunology. Research into protein glycosylation is hampered by inadequate tools to identify the full diversity of glycan structures on a proteins. We are developing Quorum, a software tool to accurately characterize glycan structures on proteins to provide important information for therapeutic and diagnostic development.
Project Terms:
adaptive immunity; Algorithms; Amino Acid Sequence Databases; analytical tool; Antibodies; Antigens; assay development; base; Basic Science; Benchmarking; CA-125 Antigen; cancer biomarkers; Characteristics; Cleaved cell; Cloud Computing; cloud platform; cluster computing; Collection; Communities; Complex; Computer software; computerized tools; Data; Data Analyses; Data Set; database structure; Databases; Development; Diagnostic; digital; Discipline; Discrimination; Disease; Disease Progression; Drug Kinetics; Engineering; Glycopeptides; Glycoproteins; glycoproteomics; glycosylation; Half-Life; Health; Human; Immunoglobulin G; Immunology; improved; instrumentation; interest; Ions; Knowledge; Libraries; Link; macromolecule; malignant breast neoplasm; Malignant neoplasm of ovary; Mass Spectrum Analysis; materials science; Metadata; Methods; Modification; Monitor; Monoclonal Antibodies; Monosaccharides; Natural Immunity; Natural Products; Neoplasm Metastasis; Noise; novel; pathogen; Pathway Analysis; peptide I; Peptides; Performance; Pharmacologic Substance; Phase; Play; Polysaccharides; Protein Analysis; Protein Glycosylation; protein phosphatase inhibitor-2; Proteins; Proteome; Proteomics; prototype; Publications; Reporting; Research; Research Personnel; Role; Signal Transduction; Site; Small Business Innovation Research Grant; Software Tools; Structure; tandem mass spectrometry; Technology; Therapeutic; therapeutic development; therapeutic protein; tool; translational impact; tumor; Urine; Variant